Investigation of five polymorphic DNA markers associated with late onset Alzheimer disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Genetika-belgrade

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2298/GENSR1302503G
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence

  2017cited by this paper
• A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

  2012cited by this paper
• Leukocyte CCR2 Expression Is Associated with Mini-Mental State Examination Score in Older Adults

  2012cited by this paper
• CCL2 Is Associated with a Faster Rate of Cognitive Decline during Early Stages of Alzheimer's Disease

  2012cited by this paper
• Ccr2-64i and Ccr5 Δ32 Polymorphisms in Patients with Late-Onset Alzheimer's disease; A Study from Iran (Ccr2-64i And Ccr5 Δ32 Polymorphisms in Alzheimer's disease).

  2012cited by this paper
• Tumor Necrosis Factor and Alzheimer's Disease: A Cause and Consequence Relationship

  2012cited by this paper
• Hematopoietic CC-Chemokine Receptor 2 (CCR2) Competent Cells Are Protective for the Cognitive Impairments and Amyloid Pathology in a Transgenic Mouse Model of Alzheimer’s Disease

  2012cited by this paper
• Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran

  2011cited by this paper
• Genetics of Late-Onset Alzheimer's Disease: Update from the Alzgene Database and Analysis of Shared Pathways

  2011cited by this paper
• CALHM1 P86L Polymorphism is a Risk Factor for Alzheimer's Disease in the Chinese Population

  2010influential reference
• Association of CALHM1 Gene Polymorphism with Late Onset Alzheimer's Disease in Iranian Population

  2010cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper
• The P86L common allele of CALHM1 does not influence risk for Alzheimer disease in Japanese cohorts

  2010cited by this paper
• Lack of Implication for CALHM1 P86L Common Variation in Italian Patients with Early and Late Onset Alzheimer's Disease

  2010cited by this paper
• CALHM1 P86L Polymorphism is Associated with Late-Onset Alzheimer's Disease in a Recessive Model

  2010influential reference
• Genome-wide analysis of genetic loci associated with Alzheimer disease.

  2010cited by this paper
• Alzheimer disease: Alzheimer disease neuropathology in the oldest old

  2009cited by this paper
• Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort.

  2008cited by this paper
• A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

  2008influential reference
• No association between CALHM1 and Alzheimer's disease risk.

  2008cited by this paper
• Systemic immune aberrations in Alzheimer's disease patients.

  2008cited by this paper
• The role of inflammation in Alzheimer's disease.

  2005cited by this paper
• CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease

  2004influential reference
• Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.

  2004influential reference
• TNFα Promoter Polymorphisms

  2004cited by this paper
• Population Survey of CCR5 &Dgr;32, CCR5 m303, CCR2b 64I, and SDF1 3´A Allele Frequencies in Indigenous Chinese Healthy Individuals, and in HIV-1-Infected and HIV-1-Uninfected Individuals in HIV-1 Risk Groups

  2003cited by this paper
• Balanced polymorphism selected by genetic versus infectious human disease.

  2003cited by this paper
• TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

  2003cited by this paper
• Characterization of chemokines and their receptors in the central nervous system: physiopathological implications

  2002cited by this paper
• The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4–positive Russians

  2002cited by this paper
• Neuroinflammation and Alzheimer's disease: Critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Molecular genetics of Alzheimer’s disease

  1993cited by this paper
• Introduction and Overview

  1989cited by this paper

• Inflammation-related gene polymorphisms associated with Parkinson’s disease: an updated meta-analysis

  2020cites this paper
• Genetic discoveries and advances in late‐onset Alzheimer’s disease

  2019cites this paper
• Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis.

  2016cites this paper
• Tumor necrosis factor-a −308 G/A polymorphism in a sample of Egyptian patients with Alzheimer′s disease

  2015cites this paper
• Genetic Factors Affecting Late-Onset Alzheimer’s Disease Susceptibility

  2015cites this paper
• First case report of Rett syndrome in the Azeri Turkish population and brief review of the literature

  2015cites this paper
• A study on association of polymorphisms in calpain10 and TCF7l2 genes with type 2 diabetes mellitus

  2015cites this paper
• Genetic Evidence for the Involvement of Variants at APOE, BIN1, CR1, and PICALM Loci in Risk of Late-Onset Alzheimer’s Disease and Evaluation for Interactions with APOE Genotypes

  2014influential citation
• Estrogen receptor alpha gene polymorphisms in patients with late onset Alzheimer’s disease

  2014cites this paper
• Distribution of apolipoprotein E gene polymorphism in students and in high-educated elderly from Serbia

  2013cites this paper